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Vertebrate mineralized tissues, i.e., enamel, dentin, cementum, and bone, have unique
hierarchical structures and chemical compositions. Although these tissues are similarly
comprised of a crystalline calcium apatite mineral phase and a protein component, they
differ with respect to crystal size and shape, level and distribution of trace mineral ions,
the nature of the proteins present, and their relative proportions of mineral and protein
components. Despite apparent differences, mineralized tissues are similarly derived by
highly concerted extracellular processes involving matrix proteins, proteases, and mineral
ion fluxes that collectively regulate the nucleation, growth and organization of forming
mineral crystals. Nature, however, provides multiple ways to control the onset, rate,
location, and organization of mineral deposits in developing mineralized tissues. Although
our knowledge is quite limited in some of these areas, recent evidence suggests that
hard tissue formation is, in part, controlled through the regulation of specific molecules
that inhibit the mineralization process. This paper addresses the role of mineralization
inhibitors in the regulation of biological mineralization with emphasis on the relevance
of current findings to the process of amelogenesis. Mineralization inhibitors can also
serve to maintain driving forces for calcium phosphate precipitation and prevent unwanted
mineralization. Recent evidence shows that native phosphorylated amelogenins have
the capacity to prevent mineralization through the stabilization of an amorphous calcium
phosphate precursor phase, as observed in vitro and in developing teeth. Based on present
findings, the authors propose that the transformation of initially formed amorphous mineral
deposits to enamel crystals is an active process associated with the enzymatic processing
of amelogenins. Such processing may serve to control both initial enamel crystal formation
and subsequent maturation.
Keywords: amorphous calcium phosphate, biomineralization, dental enamel, inhibitors, mineral phase
transformation
INTRODUCTION
Biomineralization is the process by a wide variety of living organ-
isms, including mollusks, sponges and unicellular diatoms, for
example, produce functional mineralized tissues (Mann, 2001).
Vertebrate mineralized tissues, like dental enamel, dentin, cemen-
tum, and bone, fulfill specialized functions that reflect differ-
ences in their hierarchical organization and composition (Weiner,
1986). Although each of these tissues is comprised of a crystalline
calcium apatite mineral phase and a protein component, they dif-
fer with respect to overall structure, crystal size and shape, level
and distribution of trace mineral ions, the nature of the pro-
teins present, and the relative proportions of mineral and protein
components. Differences in structural organization and com-
position give rise to mineralized tissues with different physical
and mechanical properties that are well-suited for their intended
biological purpose (Birchall, 1989; Currey, 1999).
Although the mechanisms by which these mineralized tissues
form are not fully understood, it is apparent that the unique
structure of each mineralized tissue, including dental enamel, is
the result of highly concerted cell and extracellular processes that
regulate the on-set, growth rate, shape, location and arrangement
of forming mineral crystals (Weiner, 1986). Evidence also sug-
gests that critical aspects of hard tissue formation are controlled,
in part, through the regulation of specific molecules that inhibit
mineralization. This paper addresses the role of mineralization
inhibitors in the regulation of biological mineralization and the
potential relevance of such mechanisms in the process of dental
enamel formation (amelogenesis).
FUNDAMENTAL ASPECTS OF VERTEBRATE MINERALIZED
TISSUE FORMATION
EXTRACELLULAR PROTEIN MATRIX AND MINERALIZED TISSUE
COMPOSITION
Biominerals are formed utilizing similar fundamental strategies,
although there are unique differences that distinguish one tissue
from another, especially dental enamel. Enamel, dentin and bone
www.frontiersin.org September 2014 | Volume 5 | Article 339 | 1
Margolis et al. Regulation of enamel mineral formation
are each derived from specialized cells; ameloblasts, odontoblasts
and osteoblasts, respectively. These cells secrete an extracellular
protein matrix that is predominantly comprised of a hydrophobic
protein and smaller amounts of acidic hydrophilic molecules. In
bone and dentin, the matrix is mostly collagen, while the major
enamel matrix component (>90%) is amelogenin. It has been
proposed that biomineralization is generally regulated through
interactions between hydrophobic components, which provide
a skeletal or space-filling structure (e.g., collagen in bone and
dentin), and hydrophilic (acidic) molecules (e.g., phosphophoryn
in dentin Veis et al., 1991; He et al., 2005) that regulate crys-
tal nucleation and growth (Weiner, 1986; Addadi and Weiner,
1992). Considerable evidence shows that a highly-ordered pre-
assembled collagen matrix serves as a template to guide subse-
quent mineralization, as we have previously discussed (Margolis
et al., 2006). The initial collagenous matrix is mineral free and
undergoes a series changes in structure and composition prior to
mineralization (Weinstock and Leblond, 1973; Septier et al., 1998;
Beniash et al., 2000), resulting in the formation of tissues that
are 40–50% mineral and ∼35% organic by volume (Nikiforuk,
1985). The protein matrix of forming enamel is similarly com-
prised of a predominant hydrophobic protein (amelogenin) and
two key minor protein components enamelin (hydrophilic and
acidic) and ameloblastin (amphiphilic and acidic). The obser-
vations that the amelogenin-null mouse (Gibson et al., 2001)
exhibits a marked enamel phenotype and that enamel does not
form in the absence of enamelin (Hu et al., 2008; Smith et al.,
2009) or ameloblastin (Fukumoto et al., 2004; Smith et al., 2009;
Wazen et al., 2009) are in agreement with the proposed general
requirement for hydrophobic-hydrophilic molecular interactions
in biomineral formation.
Despite similarities in the hydrophobic/hydrophilic composi-
tion of developing extracellular bone, dentine and enamel matri-
ces that lead to the formation of a similar mineral phase (i.e., a
carbonated hydroxyapatite), mature enamel and the mechanism
of its formation differ from those of dentine and bone. First, long
thin ribbons of enamel mineral begin to form almost immedi-
ately after ameloblasts lay down the enamel matrix (Nylen et al.,
1963; Arsenault and Robinson, 1989; Smith, 1998), indicating
that mineralization does not take place within a pre-assembled
enamel matrix template, as in the case of collagen-based tissues.
These long thin mineral ribbons extend hundred of microns to
the full thickness of the enamel layer that is laid down during the
secretory stage of amelogenesis, although the mineral component
occupies only 10–20% of the enamel volume, with the remain-
ing volume occupied by the enamel matrix and water (Robinson
et al., 1988; Fukae, 2002). During the maturation stage of amelo-
genesis (Robinson and Kirkham, 1985), the extracellular enamel
matrix is almost completely removed by resident proteases and
the initially formed mineral ribbons grow in width and thick-
ness to form a dense mineralized tissue that is >95% mineral by
weight, with only 1–2 weight % of remaining protein and a small
amount of water. Hence, there is an inverse relationship between
the protein and mineral content during enamel development
(Robinson et al., 1979), as illustrated in Figure 1. Unlike that seen
in bone and dentin, the enamel matrix is transient and the result-
ing enamel tissue is almost fully mineralized. The transient nature
FIGURE 1 | Inverse relationship between protein and mineral content
as a function of enamel development. Amelogenin is the major
component (>90%) of the extracellular enamel matrix in the secretory
stage. Adapted from a figure previously published by Mann (2001), with
permission from Oxford University Press. This OUP material is for view only
and cannot be reused.
of the enamel matrix is uncommon in biomineralization (Weiner,
1986).
CALCIUM PHOSPHATE FORMATION IN VITRO AND IN VIVO
The formation of a calcium phosphate mineral phase in vitro and
in vivo requires a condition of supersaturation with respect to the
forming phase. As shown in Equation 1 for hydroxyapatite (HA:
Ca5OH(PO4)3), a prototype for enamel, dentin and bone min-
eral, the degree of supersaturation (DS) can be defined as the ratio
of the mean ionic activity product for a given mineral phase in
solution to its thermodynamic solubility product constant (e.g.,
KSP−HA) defined in the same manner, where “()” represent the
activity of the enclosed ion [e.g., (Ca2+f )]. The activity of an ion
in solution is equal to the product of the concentration of the ion
([xZi ]) and an ion activity coefficient (ai) that is a function of the
ion size, charge, ionic strength and temperature. Such quantities
can be calculated using ion-speciation software, as we have pre-
viously described (Moreno and Margolis, 1988). Supersaturation
with respect to other calcium phosphate phases, such as octacal-
cium phosphate [OCP: Ca4H(PO4)3] and dicalcium phosphate
dihydrate (DCPD: CaHPO4.2H2O), can be defined similarly as
indicated in Equations (2) and (3), respectively. A minimum
requirement for mineral formation in vitro or in vivo is the con-
dition of supersaturation. As indicated by Equations 1–3, DS is a
function of calcium, phosphate and hydrogen ion activities.
DSHA =
[(
Ca2+f
)5 (
OH−
) (
PO3−4
)3]1/9/
KSP−HA (1)
DSOCP =
[(
Ca2+f
)4 (
H+
) (
PO3−4
)3]1/8/
KSP−OCP (2)
DSDCPD =
[(
Ca2+f
) (
HPO2−4
)]1/2/
KSP−DCPD (3)
where, (Xzi ) = ai × [Xzi ] and Ca2+f is free calcium.
Regarding the mineralization process, a given solution can
be supersaturated with respect to more than one calcium phos-
phate phase at the same time. Due, in part, to kinetic factors
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(for review, see Mann, 2001), however, the more soluble phase
will form first and, through a series of phase transformations,
convert to HA, which is the most thermodynamically stable cal-
cium phosphate phase of the group. This phenomenon, called the
Ostwald-Lussac law of stages, occurs in nature, as it does in vitro
(Eanes, 2001). For example, it has been shown (Schroeder, 1969)
that DCPD and OCP are the first mineral phases seen in form-
ing dental calculus that subsequently convert to HA over time.
Consistent with this observation andOstwald-Lussac law of stages,
at physiological pH (pH 7) and ionic strength (163mM), HA has
a relatively low solubility (expressed as the concentration of dis-
solved Ca2+) of 0.11mM, in comparison to OCP (1.42mM) and
DCPD (2.09mM), as calculated (Moreno and Margolis, 1988).
Such transformations may go through multiple phases before
reaching the stable HA phase, depending on the free energy of
activation (G) associated with nucleation (n), growth (g), and
phase transformation (t), as previously discussed and illustrated
in Figure 2 (Colfen and Mann, 2003).
Based on the discussion above, the role of precursor phases
involved in HA and biomineral formation has received consider-
able attention. The calcium phosphate mineral phases discussed
so far are crystalline in nature, as confirmed using spectroscopic
(FT-IR, Raman) and diffraction (X-ray and electron diffraction)
methods. However, it has been known for many years (for review,
see Eanes, 2001) that amorphous calcium phosphate (ACP) is
the first mineral phase to form upon mixing sufficiently high
concentrations of calcium and phosphate. ACP is more solu-
ble than the noted crystalline calcium phosphates and is the
kinetically favored product (Meyer and Eanes, 1978), although
it readily undergoes phase transformation to HA, as shown in
FIGURE 2 | Crystallization pathways under thermodynamic and kinetic
control, illustrating that mineral formation may go through multiple
phases (path B) before reaching the stable final crystalline product
(e.g., HA), as discussed in the text, depending on the free energy of
activation (G) associated with nucleation (n), growth (g), and phase
transformation (t). As shown, amorphous phases are frequently observed
first under kinetically controlled conditions. This figure is from a publication
(Colfen and Mann, 2003) in which this phenomenon is discussed in greater
detail and is reproduced with permission. Copyright Wiley-VCH Verlag
GmbH & Co. KGaA.
Figure 3. The presence of ACP in vertebrate mineralized tis-
sues (Posner and Betts, 1975) has been a topic of considerable
debate (Termine and Posner, 1966; Boskey, 1997; Eanes, 2001;
Weiner, 2006) because of its transient nature. However, recent
evidence suggests that the transient nature of an amorphous
mineral phase, that is, the formation of an amorphous min-
eral phase and its subsequent transformation to a crystalline
solid, is a key element in biological mineral formation (Beniash
et al., 1997; Weiner et al., 2005; Deshpande and Beniash, 2008;
Kwak et al., 2009; Margolis and Beniash, 2010; Wiedemann-
Bidlack et al., 2011). More recently, the importance of sequential
steps involving ACP formation and transformation has been con-
firmed in vitro (Habraken et al., 2013), showing that the existence
of pre-nucleation clusters that precede ACP formation lowers
the energy barrier to nucleation and makes amorphous phases
“accessible” under conditions that would favor the formation of
more stable crystalline phases. Hence, it appears calcium phos-
phate formation in vivo and in vitro similarly proceed through a
sequence of phase transformations, potentially involving: ACP→
DCPD → OCP → HA. As will be discussed below, however,
matrix molecules can dramatically influence the phase transfor-
mation process.
ROLE OF MINERALIZATION INHIBITORS IN BIOLOGICAL
MINERALIZATION
STABILIZATION OF SUPERSATURATION IN VIVO
As illustrated in Figure 3, under conditions of relatively high
supersaturation brought about by the rapid mixing of calcium
and phosphate solutions, mineralization takes place sponta-
neously. This process involves the homogeneous nucleation and
formation of precursor ACP nanoparticles, which subsequently
transform to crystalline HA. In the absence of a buffer, this pro-
cess causes a sharp decrease in pH due to the precipitation of
a basic solid phase (Figure 4). In the presence of the full-length
native amelogenin, P173, the solution pH does not drop and
remains relatively constant for long periods of time, as illustrated
in Figure 4, by preventing the bulk formation of HA crystals, as
shown in Figure 5 (Wiedemann-Bidlack et al., 2011). As can be
seen in this TEM micrograph, P173 has the capacity to stabilize
initially formed nanoparticles of ACP and prevent transforma-
tion to crystalline HA, as seen in the control (Figure 3). Of note,
truncated native amelogenin, P148 that lacks the hydrophilic C-
terminus was similarly found to be a potent stabilizer of ACP
(Kwak et al., 2009). Hence, P173 and P148 are inhibitors of spon-
taneous HA crystal formation. In doing so, the supersaturation
status of the experimental solution is also maintained, along with
its inherent stored capacity to promote mineralization. Notably,
native amelogenins like P173 and P148 contain a single phospho-
rylated site (serine-16) within the N-terminus (Margolis et al.,
2006), as further discussed below.
The stabilization of biological fluids through the inhibition of
HA crystal formation is well known and appears to fulfill bio-
logically important functions. A prime example is human saliva
that has been shown (Hay et al., 1982) to be supersaturated with
respect to all known calcium phosphate phases. Evidence sug-
gests that this condition of supersaturation is maintained by a
family of salivary phosphoproteins, which have been shown to
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FIGURE 3 | TEM micrographs of calcium phosphate mineral products
formed in the absence (control) of protein examined at selected times:
15min (A), 45min (B), 1–4h (C), and 1d (D). As shown at 15min (A),
amorphous calcium phosphate (ACP) was initially formed based on the
observed (inset) selected area electron diffraction (SAED) pattern. At 45min,
ACP phase transformation could be seen. After 1–4 h, randomly arranged
plate-like apatitic crystals were found and confirmed by SAED analyses (D,
inset). This image was reproduced from Kwak et al. (2009).
FIGURE 4 | Changes in pH as a function of time observed during
mineralization experiments carried out in 60µL sample volumes, in
the absence (A) and presence of native full-length amelogenin, P173,
at 2 mg/mL (B). This image was reproduced from Wiedemann-Bidlack
et al. (2011).
be potent inhibitors of spontaneous calcium phosphate forma-
tion and seeded HA crystal growth in vitro (e.g., Hay et al.,
1979). Under these conditions that persist in human saliva, cal-
cium phosphate formation on hard and soft tissue surfaces in the
oral cavity is prevented, as is the dissolution of tooth enamel in
saliva. If saliva did not contain calcium and phosphate ions it
would be undersaturated with respect to tooth enamel (i.e., with
DSEN < 1) and potentially promote the dissolution of enamel
surfaces, albeit at a very slow rate. In fact, the observed spon-
taneous reversal of untreated early carious lesions (Koulourides
et al., 1965; Dirks, 1966), where incipient lesions (i.e., white
spots) take up mineral ions to become sound surfaces, can be
attributed to the condition of saliva supersaturation. Hence, the
prevention of unwanted mineral deposits in the oral cavity and
the capacity of saliva to promote the repair (remineralization) of
beginning enamel lesions is due to resident inhibitors of calcium
phosphate formation that maintain saliva in its supersaturated
state. Similarly, inhibitors of calcium oxalate formation have been
FIGURE 5 | TEM micrograph of calcium phosphate mineral products
formed in the presence of native full-length amelogenin, P173, at
2mg/mL. Only ACP was observed, even after 1 d, as confirmed by
selected area electron diffraction (inset). This image was reproduced from
Wiedemann-Bidlack et al. (2011).
identified in urine and are believed to play an important role in
preventing the formation of kidney stones (e.g., Nene et al., 2013).
Finally, it has been shown that spontaneous calcification of arter-
ies and cartilage takes place in mice that lack the mineral binding
matrix GLA protein, a known mineralization inhibitor. These lat-
ter observations, lead the authors of that study to conclude that
the calcification of the extracellular matrix is a ubiquitous process
that must be actively inhibited in soft tissues that do not normally
mineralize (Luo et al., 1997).
REGULATION OF BIOMINERAL FORMATION
Mann (2001) summation that “The chemical control of crystal-
lization pathways that involve a sequence of kinetic inhibition and
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phase transformation can result in a high degree of selectivity in
crystal structure and composition,” is perhaps best illustrated in
biology where numerous inhibitors of HA formation have been
identified, including magnesium ion, carbonate, proteoglycans,
polyphosphate and other phosphorylated molecules. In partic-
ular, inorganic pyrophosphate (PPi) has been long recognized
as a potent inhibitor of mineralization and as a potential reg-
ulator of biological mineralization. At micro-molar levels, PPi
inhibits the growth (Francis, 1969; Meyer and Nancollas, 1973;
Meyer, 1984; Moreno et al., 1987) and dissolution (Fleisch et al.,
1966; McGaughey and Stowell, 1977; McGaughey, 1983) of HA,
as well as HA crystal formation from ACP (Termine et al.,
1970; Robertson, 1973; Blumenthal et al., 1975). A study in
our laboratory (Moreno et al., 1987) indicated that the inhi-
bition of HA crystal growth results from PPi adsorption to
discrete growth sites on HA surfaces, in the same fashion that
has been proposed to explain the inhibition of crystal growth by
macromolecules (Moreno et al., 1979). Stabilization of ACP may
similarly involve PPi binding to ACP nanoparticles (Ofir et al.,
2004).
Based on additional in vitro findings (Meyer, 1984) that sug-
gest calcification cannot occur in vivo in the presence of physi-
ological levels of PPi, it was proposed (Meyer and Reddi, 1985)
that pyrophosphatases regulate mineral deposition in bone and
cartilage by hydrolyzing PPi (to two molecules of orthophos-
phate) to eliminate its inhibitory activity. This overall concept
has been supported by the elucidation (Ho et al., 2000) of the
role of progressive ankylosis (ank) gene that encodes a trans-
membrane protein that appears to regulate calcification (and
arthritis) by controlling both intracellular and extracellular lev-
els of PPi. Additional evidence has also been obtained showing
that tissue non-specific alkaline phosphatase (TNAP) and plasma
cell membrane glycoprotein-1 (PC-1) are key enzyme regulators
of the extracellular PPi concentrations required for controlled
bone mineralization (Hessle et al., 2002). PC-1 is the major
producer of the PPi inhibitor, while TNAP can regulate the pro-
motion of the onset of bone mineralization by hydrolyzing PPi.
Consistent with this idea, it has been demonstrated in vitro that
upon the removal of PPi from solution, either through adsorp-
tion or by HA surface-induced hydrolysis (Meyer, 1984; Litman
and Margolis, unpublished findings), or by enzymatic degrada-
tion of PPi, PPi-stabilized calcium phosphate solutions rapidly
form calcium phosphates.
With respect to amelogenesis, alkaline phosphatase (AP) has
been found in secretory enamel, leading investigators to sug-
gest that “dephosphorylation” of amelogenin (e.g., by AP) may
play a role in regulating enamel formation (Brookes et al., 1998).
Although this suggestion has not been fully substantiated in vivo,
a study using cultured embryonic tooth germs showed that non-
specific inhibition of phosphorylation by casein kinase impaired
enamel formation (Torres-Quintana et al., 2000), lending sup-
port to the idea that phosphorylated enamel matrix proteins may
play a role as mineralization inhibitors. More recently, it has
been reported that TNAP is expressed by normal ameloblasts in
a stage-specific manner, that is, at the point of transition from
secretory to maturation stage (Yadav et al., 2012). In addition,
AP was found to be highly expressed by the adjacent stratum
intermedium of the developing enamel organ. Importantly, this
latter study also showed that the TNAP knockout mice not only
exhibited a phenotype similar to infantile hypophosphatasia, but
also marked enamel defects, including reduced mineralization
and disrupted rod and interrod structures. Hence, the reversal
of mineralization inhibition, by PPi hydrolysis or dephosphory-
lation, may represent a critical regulatory step in the formation of
both developing bones and teeth.
Upon mineral growth, macromolecules found in bones and
teeth can also effectively influence the morphology of calcium
phosphate minerals through adsorption to specific crystal planes
(e.g., Furedi-Milhofer et al., 1994; Flade et al., 2001). Of particu-
lar interest are observations that amelogenin (Iijima et al., 2001,
2002; Beniash et al., 2005), as well as other relevant biomineral-
ization molecules like phosphophoryn (Burke et al., 2000) and
glucose (Walsh et al., 1993), preferentially adsorb on (100), (010)
faces of HA or OCP, suppressing their growth in a- and b-axis
directions. Consequently, under these conditions, such crystals
grow preferably along the long c-axis forming ribbon or needle-
like structures resembling enamel crystals. As described in the
next section, current evidence suggests that native amelogenins
have the capacity to stabilize ACP, prevent unwanted crystalliza-
tion, and ultimately guide the formation and organization of
bundles of aligned enamel crystals during the secretory stage of
enamel formation. The authors hypothesize, however, that the
transformation of ACP to HA and the subsequent growth of HA
crystals in thickness and width during maturation are the result
of active regulation processes.
MECHANISM OF DENTAL ENAMEL FORMATION
Studies from our laboratory suggest that amelogenin mediates
mineralization through a cooperative mechanism where mineral-
ization and protein self-assembly occur simultaneously (Beniash
et al., 2005). This conclusion is based on in vitro findings
that show that the non-phosphorylated full-length recombi-
nant mouse amelogenin, rM179, can guide the formation of
well-aligned bundles of HA crystals in vitro, under experimen-
tal conditions designed to simultaneously induce amelogenin
assembly and mineralization. Organized mineral formation was
not observed when protein self-assembly was carried out prior
to mineralization or when a truncated recombinant mouse
amelogenin (rM166, lacking the hydrophilic C-terminus) was
used. Similar results were subsequently obtained under cooper-
ative assembly/mineralization conditions using recombinant full-
length porcine amelogenin, rP172, which was also found to guide
the formation of bundles of aligned HA crystals (Kwak et al.,
2009). These latter experiments were monitored as a function
of time to provide insight into the mechanism of amelogenin-
mediated mineralization. These studies revealed that rP172
transiently stabilizes ACP nanoparticles (Figure 6), which were
found to be significantly smaller than those seen in the control
(Figure 3). As the reaction continued in the presence of rP172,
an alignment of ACP nanoparticles was observed at ∼45min.
Arrays of needle-like crystals were then observed between 1–4 h.
At 24 h, as shown, multiple bundles of well-aligned needle-like
apatite crystals were seen that are similar to those found in the
presence of rM179 (Beniash et al., 2005) and distinctly different
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FIGURE 6 | TEM micrographs of calcium phosphate mineral products
formed in the presence of 2mg/ml recombinant full-length
amelogenin, rP172, examined at selected times: 15min (A), 45min (B),
1–4h (C), and 1 d (D). ACP particles seen at 15min (A, inset) were found
to align to form need-like particles (arrows) at 45min (B). After 1 d, based
on selected area electron diffraction analyzes (D, inset), aligned bundles of
needle-like apatitic crystals were formed. This image was reproduced from
Kwak et al. (2009).
in comparison to the randomly arranged plate-like crystals found
in the control (at 24 h, Figure 3). Truncated recombinant (non-
phosphorylated) porcine amelogenin rP147 had relatively lit-
tle effect on the mineralization process (Kwak et al., 2009),
again indicating that the full-length amelogenin has a unique
capacity to guide ordered mineralization. This unique capac-
ity is attributed to the fact that full-length recombinant mouse
(rM179) and porcine (rP172) amelogenin, as well as full-length
native amelogenin (P173), undergo self-assembly to form hier-
archical nanosphere (Fang et al., 2011, 2013) and chain-like
(Wiedemann-Bidlack et al., 2007, 2011) structures, as a function
of solution pH. Truncated amelogenins lacking the hydrophilic
C-terminus do not form such organized structures. Notably,
the single phosphate group in native amelogenins on serine-16
was found to have only a subtle influence on P173 assembly
and structure, as determined by both conventional (Wiedemann-
Bidlack et al., 2011) and cryo-TEM (Fang et al., 2013). However,
small-angle X-ray scattering studies using phosphorylated and
non-phosphorylated leucine-rich amelogenin peptides (LRAP,
an alternative splice product that is comprised of the first 33
amino acids and the last 23 C-terminal amino acids of full-length
(porcine) amelogenin) showed that phosphorylation of serine-16
had a significant effect on the folding of the peptide in solution
(Le Norcy et al., 2011a). LRAP(+P) exhibited an unfolded struc-
ture, while LRAP(-P) exhibited a globular structure in solution.
LRAP(+P), like P173, was also found to effectively stabilize ACP
and inhibit HA formation in vitro (Le Norcy et al., 2011b). These
influences on protein structure and folding may be of consider-
able functional importance, given the marked effect phosphory-
lation has on the capacity of native amelogenins to stabilize ACP
and inhibit HA formation for extended periods of time, as further
discussed below.
In recent years, two prominent theories of crystal growth—
aptly named the classical and non-classical crystal growth the-
ories, have received considerable attention, in part, through
detailed investigations into the growth mechanisms of biomin-
erals (Niederberger and Colfen, 2006). The classical mechanism
for crystal growth is mineral ion mediated where mineral growth
progresses through the successive accumulation of mineral ions
to form a single crystal. The non-classical mechanism for crys-
tal growth is mediated by initially formed nano-particles that
subsequently assemble in an organized fashion to form what
appear to be single crystals (so-called mesocrystals). Although it
is often difficult to distinguish between these two mechanisms,
early studies (Robinson et al., 1981; Robinson, 2007) have sug-
gested that, during amelogenesis, enamel crystals form through
the assembly of small amorphous mineral particles, although
the amorphous nature of these particles was not verified exper-
imentally. Since this initial proposal, however, data have been
obtained that support the presence of ACP in the developing
enamel matrix (Diekwisch, 1998; Bodier-Houlle et al., 2000). In
a more recent study (Beniash et al., 2009), multiple indepen-
dent techniques were used to carefully characterize the phase of
the long thin parallel arrays of mineral deposits (e.g., as seen in
Figure 7) that form during the secretory stage of amelogenesis
that begin near the DEJ and extend to the enamel surface. Newly
deposited mouse enamel, that is, in the outer enamel layers closer
to the enamel surface and the ameloblast layer was found to be
ACP, while older enamel, found in inner layers of enamel closer
to DEJ contained apatitic crystals. Of particular importance, the
newly deposited amorphous mineral and the older crystalline
deposits had the same ribbon-like shape and organization in
parallel arrays. These findings suggest that enamel mineral mor-
phology and organization are established by the enamel matrix
prior to the transformation of ACP to HA-like enamel crystals.
These findings are also consistent with a proposed hypothesis
that initial enamel crystals form from the assembly and fusion of
amorphous calcium phosphate particles (e.g., Robinson, 2007).
Transient amorphous mineral phases (i.e., ACP and amorphous
calcium carbonate) have also been observed to be associated with
a number of other biomineralization systems (Lowenstam and
Weiner, 1985, 1989; Beniash et al., 1997; Wu et al., 1997; Levi-
Kalisman et al., 2000; Aizenberg et al., 2002), including bone
(Kim et al., 2005; Crane et al., 2006; Mahamid et al., 2008),
leading to the proposal that the transformation of amorphous
phases to crystalline materials is an important aspect of biolog-
ical mineralization (Beniash et al., 1997; Weiner et al., 2005).
Other molecules believed to be associated with the regulation of
biomineralization, like highly phosphorylated osteopontin from
milk (Gericke et al., 2005) and the N-terminal domain of dentin
matrix protein 1 (Gajjeraman et al., 2007) have been shown to
stabilize ACP.
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POTENTIAL ROLE OF MINERALIZATION INHIBITORS IN DENTAL
ENAMEL FORMATION
Based on current evidence, inhibition of mineralization by native
amelogenins and its reversal in vivo may play critical roles in
enamel formation. This conclusion is supported by data showing
(1) an inverse relationship between protein and mineral content
(Figure 1), and the notably high protein and low mineral content
(10–20% by volume) of secretory stage enamel; (2) the capacity
of native amelogenins to stabilize ACP and inhibit mineraliza-
tion in vitro; (3) the apparent requirement for both proteases
[i.e., matrix metalloproteinase 20 (MMP20) during the secre-
tory stage Caterina et al., 2002 and kallikrein 4 (Klk4) during
transition/maturation Hu et al., 2000; Simmer et al., 2009] and
phosphatases (i.e., AP, as discussed above) for proper enamel
formation; and (4) the rapid onset of mineral growth coincid-
ing with loss of protein (Figure 1). These collective data suggest
that during the secretory stage of enamel formation, enamel
matrix proteins selectively guide ACP nanoparticle organization
and transformation to thin ribbons of co-aligned HA crystals,
while at the same time preventing unwanted bulk mineraliza-
tion. Support for this scenario was recently provided by in vitro
findings showing that under the proper kinetic conditions, con-
trolled by variations in protein concentration, significantly lower
concentrations of P173 can guide the transformation of initially
stabilized ACP nanoparticles to ordered bundles of HA crystals
that have similar morphology to initially formed enamel crystals
(Kwak et al., 2014). In contrast to that seen with P173, however,
P148 lacked the capacity to regulate ordered mineralization at
reduced protein concentrations, although mineralization did take
place. At higher concentrations, again, both P173 and P148 are
potent stabilizers of ACP. Hence, upon its secretion, the parent
phosphorylated full-length amelogenin P173 can initially prevent
FIGURE 7 | Transmission electron microscopy micrograph of secretory
stage mouse enamel showing parallel arrays of long thin ribbons of
mineral.
premature mineralization of HA crystals in forming enamel.
However, full-length amelogenin undergoes proteolytic process-
ing soon after secretion, resulting in a significant decrease in its
concentration. In developing porcine enamel, the P173 content
of secretory enamel was found to be only 7.4% of total amel-
ogenin, a reduction in P173 by more than 90% (Wen et al.,
1999). P173 was also found to be exclusively associated with
newly formed enamel mineral (Uchida et al., 1991). In contrast
to P173, the P148 content of the enamel matrix increases and
becomes the predominant amelogenin cleavage product at 49.5%
of total amelogenin (Wen et al., 1999). Based on these combined
in vitro and in vivo findings, the authors propose that the onset
of enamel crystal formation is regulated by a marked reduction
(>10-fold) in P173 concentration to attain a critical lower level
that has the potential to organize forming mineral deposits into
oriented bundles of elongated HA crystals, as illustrated in a
proposed model presented in Figure 8. At the same time, sub-
stantially higher concentrations of P148 (∼ 6–7 times higher than
P173) that accumulate in the developing (porcine) enamel matrix
serve an important role by preventing uncontrolled mineraliza-
tion throughout the secretory stage of amelogenesis where the
mineral volume is only 10–20% (Robinson et al., 1988; Fukae,
2002).
The noted proteolytic processing of amelogenin during the
secretory stage of amelogenesis has been primarily attributed to
MMP20 that is exclusively expressed during this initial stage of
enamel formation. MMP20 has also been shown to be essen-
tial for proper enamel formation (Caterina et al., 2002). In its
absence, the enamel layer is about one-half the normal thickness
FIGURE 8 | Proposed model illustrating the potential role of P173 and
P148 in dental enamel formation. The onset of the initial formation of
linear arrays of ACP (A) during the secretory stage is brought about by the
marked reduction of P173 by MMP20, reversing its inhibitory effect.
Limited quantities of P173 (red) stabilize linear ACP arrays through direct
interaction, as illustrated. The predominant P148 (gray) cleavage product
plays a key role in preventing unwanted mineralization, while maintaining
conditions of supersaturation. The linear arrays of ACP subsequently
transform to apatitic crystals (Beniash et al., 2009) during the secretory
stage (B). During maturation, inhibition of bulk mineralization provided by
P148 is eliminated by Klk4 proteolysis, along with small amounts of
adsorbed P173 growth inhibitor, to initiate the lateral growth of initial
enamel ribbons (C). As noted in the text, AP may also play an essential role
in regulating mineral formation in the secretory stage and mineral growth
during the maturation stage by catalyzing amelogenin dephosphorylation.
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and the decussating prism pattern of normal enamel is substan-
tially disrupted. These latter findings verify that proteolytic pro-
cessing of full-length amelogenin is required for proper enamel
formation, consistent with our proposed model, that is based
on the capacity of reduced levels of P173 to guide ordered
HA crystal formation, while accumulating P148 levels maintain
mineralization driving forces by preventing unwanted bulk min-
eralization. During maturation, Klk4 is predominantly expressed
and is believed to be responsible for removing almost all of the
remaining enamel matrix to allow the initial enamel crystals to
grow in width and thickness (Hu et al., 2000). Hence, as illustrated
in the presented model, we propose that the onset of mineraliza-
tion during the secretory stage is brought about by the marked
reduction of P173 content by MMP20, reversing its inhibitory
effect. During maturation, inhibition of bulk mineralization pro-
vided by P148 is eliminated by Klk4 proteolysis, along with small
amounts of adsorbed P173 growth inhibitor, to initiate the lateral
growth of the secretory stage enamel ribbons. As noted above, AP
may also play an essential role in regulating mineral formation
in the secretory stage and mineral growth during the maturation
stage by catalyzing amelogenin dephosphorylation and removing
the noted mineralization inhibitory activity found to be asso-
ciated with native amelogenins. The timing of the expression
of key regulators of biomineralization during enamel formation
is, therefore, of critical importance (e.g., Smith, 1998; Simmer
et al., 2009). Additional studies addressing the potential roles
of amelogenin proteolysis and de-phosphorylation in regulating
initial enamel mineral formation and maturation are currently
underway in our laboratory.
CONCLUSIONS
Mineralization inhibitors can play critical roles in regulating min-
eralized tissue formation, stability, and regeneration in vivo. With
respect to dental enamel formation, mineralization events trig-
gered by the proteolysis and/or de-phosphorylation of full-length
native amelogenin during the secretory stage of amelogenesis may
play an essential role in regulating enamel mineral formation and
its hierarchical structure, while predominant amelogenin degra-
dation products, like P148, serve to prevent uncontrolled mineral
formation. During maturation, residual inhibition is removed via
additional matrix processing, allowing initial enamel crystals to
expand to form the highly dense enamel mineral layer.
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